Anti-VEGF Therapy Switching in Neovascular Age-Related Macular Degeneration: Insights from Automated Volumetric Retinal Fluid Analysis
Automated fluid analysis reliably quantifies treatment response in nAMD. Early switchers showed worsening after bevacizumab, while late switchers had partial responses. These findings highlight the potential of automated analysis to support more individualized, data-driven treatment strategies. Prospective studies are required to confirm impact on patient outcomes.
Authors
- Noam Shomron (ORCID: https://orcid.org/0000-0001-9913-6124)
- Marganit Shahar-Gonen
- Qing Wen (ORCID: https://orcid.org/0000-0003-4325-7829)
- Reut Shor
- Moshe Havilio
- A. Loewenstein
- Gidi Benyamini (ORCID: https://orcid.org/0000-0003-4496-8462)
- D. M. Wright
- Dinah Zur
- Omer Dor
- Tunde Peto
- May Cohen
Institutions
- Queen's University Belfast (GB)
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Notal Vision (Israel) (IL)
Publication Details
- Journal
- Retina
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1097/iae.0000000000004756
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00